摘要
目的观察丁苯酞注射液联合依达拉奉治疗急性脑梗死的临床疗效。方法 208例急性脑梗死患者,按照患者治疗意愿不同分为联合组和单一组,每组104例。联合组患者在常规治疗基础上加用丁苯酞注射液联合依达拉奉治疗,单一组患者在常规治疗基础上加用依达拉奉治疗,对比两组患者治疗效果。结果治疗前,两组患者日常生活活动能力量表(ADL)评分、美国国立卫生研究院卒中量表(NIHSS)评分比较差异无有统计学意义(P>0.05)。治疗后,联合组患者ADL评分、NIHSS评分明显优于单一组患者,差异具有统计学意义(P<0.05)。联合组患者临床治疗有效率为96.2%,明显高于单一组患者的86.5%,差异具有统计学意义(P<0.05)。结论在常规治疗基础上加用丁苯酞注射液联合依达拉奉治疗急性脑梗死,不仅可以提高临床治疗的效果和质量,同时也能够改善患者ADL评分、NIHSS评分,具有理想的治疗效果。
Objective To observe clinical effect by butyphthalide injection combined with edaravone in the treatment of acute cerebral infarction.Methods A total of208patients with acute cerebral infarction were divided by their treatment willingness into combined group and single group,with104cases in each group.The combined group received additional butyphthalide injection combined with edaravone for treatment to conventional therapy,and the single group received additional edaravone for treatment to conventional therapy.Curative effects were compared between the two groups.Results Before treatment,there was no statistically significant difference of activities of daily living(ADL)score and National Institutes of Health Stroke scale(NIHSS)score between the two groups(P>0.05).After treatment,the combined group had all better ADL score and NIHSS score than the single groups,and their difference had statistical significance(P<0.05).The combined group had obviously higher effective rate in clinical treatment as96.2%than86.5%in the single group,and their difference had statistical significance(P<0.05).Conclusion Additional implement of butyphthalide injection combined with edaravone for treatment to conventional therapy can improve effect and quality of clinical treatment,as well as ADL score and NIHSS score in patients.This method contains ideal curative effect.
作者
王瑶
WANG Yao(Ward Two of Department of Neurology, Tieling City Central Hospital,Tieling 112000, China)
出处
《中国现代药物应用》
2017年第8期85-87,共3页
Chinese Journal of Modern Drug Application
